
Sign up to save your podcasts
Or


In these bonus episodes called 'Industry Updates', we'll bring you up to speed with news of important and pressing issues. These episodes are published ad hoc and don't replace our usual Friday podcasts!
Chapter 1 of our Industry Updates was impromptu recording with Dr. John Holbrook and Dr. John Delaney from Fresh Clinics. Being the biggest compliance and scripting company in Australia, we quickly arranged this talk to discuss the impact of the Queensland Health fact sheet. This has sent shockwaves across the state and the wider injecting community around Australia.
The document was released by Queensland Health in December and it highlights a number of regulations including the purchasing and storage requirements for Schedule 4 medications and the necessity for having doctors physically on-site in nurse-owned clinics.
Our guests share insights from their own conversation with the regulators, their webinar feedback with their nurse customers and the broader implications for Australian cosmetic clinics. Our guests conclude by emphasizing the importance of patient safety, legal compliance and the practical realities for many nurse-led clinics.
00:00 Introduction and Purpose
00:03 Regulatory Update Overview
01:36 Details of the Fact Sheet
03:48 Industry Reactions and Webinars
05:10 Legal Interpretations and Concerns
14:28 Future Steps and Industry Impact
19:32 Broader Implications for Other States
26:19 Closing Remarks and Final Thoughts
ALL IA LINKS & CONTACT INFORMATION
By Inside Aesthetics4.9
8080 ratings
In these bonus episodes called 'Industry Updates', we'll bring you up to speed with news of important and pressing issues. These episodes are published ad hoc and don't replace our usual Friday podcasts!
Chapter 1 of our Industry Updates was impromptu recording with Dr. John Holbrook and Dr. John Delaney from Fresh Clinics. Being the biggest compliance and scripting company in Australia, we quickly arranged this talk to discuss the impact of the Queensland Health fact sheet. This has sent shockwaves across the state and the wider injecting community around Australia.
The document was released by Queensland Health in December and it highlights a number of regulations including the purchasing and storage requirements for Schedule 4 medications and the necessity for having doctors physically on-site in nurse-owned clinics.
Our guests share insights from their own conversation with the regulators, their webinar feedback with their nurse customers and the broader implications for Australian cosmetic clinics. Our guests conclude by emphasizing the importance of patient safety, legal compliance and the practical realities for many nurse-led clinics.
00:00 Introduction and Purpose
00:03 Regulatory Update Overview
01:36 Details of the Fact Sheet
03:48 Industry Reactions and Webinars
05:10 Legal Interpretations and Concerns
14:28 Future Steps and Industry Impact
19:32 Broader Implications for Other States
26:19 Closing Remarks and Final Thoughts
ALL IA LINKS & CONTACT INFORMATION

1,146 Listeners

45 Listeners

130 Listeners

4,092 Listeners

1,107 Listeners

1,373 Listeners

1,245 Listeners

1,454 Listeners

160 Listeners

6,087 Listeners

1,652 Listeners

20,363 Listeners

1,187 Listeners

15 Listeners

1,022 Listeners